SCHEMBL24309576

SCHEMBL24309576

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Cl)c1C(C)(C)C

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.33
▸ JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310486 0.90 JAK2 (0.32) JAK2JAK1
SCHEMBL24309815 0.89 JAK2 (0.34) JAK2JAK1
SCHEMBL24309723 0.87 JAK2 (0.34) JAK2JAK1
SCHEMBL24309647 0.86 MAP3K7 (0.32) —
SCHEMBL24309836 0.85 JAK2 (0.33) JAK2JAK1
SCHEMBL24310590 0.85 IGF1R (0.31) JAK2JAK1
SCHEMBL24309551 0.84 FYN (0.32) —
SCHEMBL24310169 0.84 FLT4 (0.31) —
SCHEMBL24310692 0.84 JAK2 (0.33) JAK2JAK1
SCHEMBL24310222 0.83 KDM5B (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback